AngioDynamics wins court ruling invalidating three Bard patents in Delaware litigation

ANGIODYNAMICS INC

District Court granted AngioDynamics' Renewed Judgment as a Matter of Law on June 1, 2023.
Three U.S. patents (8,475,417; 8,545,460; 8,805,478) declared invalid as anticipated, indefinite, and ineligible.
Court also found no willful infringement by AngioDynamics.
Bard may appeal the ruling to the Federal Circuit; AngioDynamics believes it supports defenses in other pending cases.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.